Indeed, by looking at the top 16 TFs, when translating PC3 to HA1E, we can observe TFs such as E2F2, MYC, FOXM1, RELA, JUN, FOSM, even TP53 which is often a therapeutic target of anti-cancer therapeutics, and others (Fig. 4f). This evidence concerns the gene E2F2 and cancer.